Stock listing

Hanall Biopharma Co., Ltd.

Selected listing: 009420 · KRX · KRW · KR

Hanall Biopharma Co., Ltd. (KRX:009420), Health Technology. Latest release Mar 17, 2025: HanAll Biopharma Announces Orphan Drug Designation for Batoclimab…

009420:KRXKRWKRUpdated October 2, 2026
Hanall Biopharma Co., Ltd. logo
Ticker
KRX:009420
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
KRX
Currency
KRW

About Hanall Biopharma Co., Ltd.

Hanall Biopharma Co., Ltd. is a public company listed under the ticker 009420 on the Korean market. Hanall Biopharma focuses on developing innovative biopharmaceuticals to address unmet medical needs.

Latest news from Hanall Biopharma Co., Ltd.

HanAll Biopharma Announces Orphan Drug Designation for Batoclimab in Japan for Active Thyroid Eye Disease

March 16, 2025

All Hanall Biopharma Co., Ltd. news →

Research Hanall Biopharma Co., Ltd.

Hanall Biopharma Co., Ltd. company profile

View the public company page for Hanall Biopharma Co., Ltd. on 6ix.

Hanall Biopharma Co., Ltd. news

Read company news and market updates connected to Hanall Biopharma Co., Ltd..

Hanall Biopharma Co., Ltd. investor events

Find investor webinars, events, and replay context for Hanall Biopharma Co., Ltd..